Indivior Pharmaceuticals, Inc.（INDV）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 Indivior Pharmaceuticals, Inc.（INDV）报告了 48 笔 Form 4 交易（最近一笔 2026-08-27）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-27 | Anderson Woodrow D | Chief Accounting Officer | 买入 | 1,500 | $53,535 |
| 2026-08-05 | Anderson Woodrow D | Chief Accounting Officer | 买入 | 1,500 | $54,420 |
| 2026-07-13 | Heidbreder Christian | Chief Scientific Officer | 卖出 | 18,586 | $764,628 |
| 2026-06-23 | Ciaffoni Joseph | Chief Executive Officer | 买入 | 1.3M | $0 |
| 2026-06-23 | Ciaffoni Joseph | Chief Executive Officer | 卖出 | 612,549 | $23.5M |
| 2026-06-12 | Heidbreder Christian | Chief Scientific Officer | 卖出 | 18,586 | $707,383 |
| 2026-06-10 | Preblick Ryan | Chief Financial Officer | 卖出 | 36,000 | $1.4M |
| 2026-05-14 | Kingsley Stuart A | 董事 | 买入 | 6,518 | $0 |
| 2026-05-14 | Stejbach Mark | 董事 | 买入 | 6,518 | $0 |
| 2026-05-14 | Ryan Barbara | 董事 | 买入 | 6,518 | $0 |
| 2026-05-14 | NINIVAGGI DANIEL A | 董事 | 买入 | 6,518 | $0 |
| 2026-05-14 | Thompson Juliet | 董事 | 卖出 | 1,117 | $42,759 |
| 2026-05-14 | Thompson Juliet | 董事 | 买入 | 6,518 | $0 |
| 2026-05-14 | Wheadon David E. | 董事 | 买入 | 10,430 | $0 |
| 2026-05-14 | Humphreys Keith | 董事 | 买入 | 6,518 | $0 |
| 2026-03-17 | Preblick Ryan | Chief Financial Officer | 买入 | 6,302 | $0 |
| 2026-03-17 | Preblick Ryan | Chief Financial Officer | 卖出 | 2,843 | $88,446 |
| 2026-03-13 | Ryan Barbara | 董事 | 买入 | 8 | $249 |
| 2026-03-11 | Ryan Barbara | 董事 | 买入 | 31 | $1,009 |
| 2026-03-11 | Kingsley Stuart A | 董事 | 买入 | 940 | $29,958 |
| 2026-03-05 | Burris Jeffrey W | Chief Legal Officer | 买入 | 79,893 | $0 |
| 2026-03-05 | Burris Jeffrey W | Chief Legal Officer | 卖出 | 36,032 | $1.2M |
| 2026-03-05 | Anderson Woodrow D | Chief Accounting Officer | 买入 | 18,364 | $0 |
| 2026-03-05 | Anderson Woodrow D | Chief Accounting Officer | 卖出 | 8,283 | $264,890 |
| 2026-03-05 | Anderson Woodrow D | Chief Accounting Officer | 买入 | 5,946 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27